Qiagen
Logotype for Qiagen N.V.

Qiagen (QGEN) investor relations material

Qiagen Investor presentation summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Qiagen N.V.
Investor presentation summary16 Jan, 2026

Financial performance and outlook

  • Q3 2025 net sales reached $533 million (+5% CER), with core sales up 6% CER, exceeding outlook for ≥5%.

  • Adjusted diluted EPS was $0.61 (+7% CER), above the outlook of ≥$0.58 CER; adjusted operating income margin steady at 29.6%.

  • 9M 2025 operating cash flow was $466 million, down 3% year-over-year, with free cash flow at $336 million.

  • FY 2025 net sales expected to grow 4-5% CER (core: 5-6% CER); adjusted EPS outlook raised to ~$2.38 CER.

  • $500 million share repurchase program to be completed in January 2026, with at least $1 billion in shareholder returns planned for 2024-28.

Business segment highlights

  • QIAstat-Dx and QuantiFERON led growth in Q3 2025, each up 11% CER; Sample technologies grew 3% CER.

  • QIAcuity digital PCR and QIAGEN Digital Insights (QDI) delivered solid double-digit CER growth, driven by clinical applications and Genoox integration.

  • Sample technologies saw strong demand for automated consumables and instrument placements, especially QIAcube, QIAsymphony, and EZ2 systems.

  • FDA clearance for QIAstat-Dx Rise enabled U.S. launch, automating up to 18 tests simultaneously.

  • Acquisition of Parse Biosciences expands into the high-growth single-cell market, expected to contribute ~$40 million sales in 2026.

Operational and strategic initiatives

  • Continued focus on operational excellence, digitization, and process optimization, including S/4HANA ERP upgrade.

  • Portfolio expansion with three new automation launches and integration of Parse Biosciences.

  • Disciplined capital allocation with targeted organic investments and value-creating M&A.

  • Empowered workforce of ~5,700 employees, with a strong culture of accountability and recognition as a top employer.

  • ESG initiatives include a net zero carbon emission target by 2050 and 37% female leadership in 2024.

Which growth pillar has highest 2028 sales target?
Parse Biosciences EPS accretion timeline
Key operational levers for 2028 margin
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Qiagen earnings date

Logotype for Qiagen N.V.
Q4 20255 Feb, 2026
Qiagen
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Qiagen earnings date

Logotype for Qiagen N.V.
Q4 20255 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Qiagen N.V. is a global biotechnology company specializing in sample and assay technologies for molecular diagnostics, life sciences research, and pharmaceutical development. The company provides solutions for DNA, RNA, and protein analysis, serving applications in disease detection, genetic research, and forensic testing. Qiagen’s products include reagents, instruments, and bioinformatics software used by healthcare providers, academic institutions, and biopharmaceutical companies. Qiagen N.V. is headquartered in Venlo, Netherlands, and its shares are listed on the NYSE and the Frankfurt Stock Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage